Navigating the PCSK9 Inhibitor Frontier

0 reviews

Haymarket Medical Education

1 hour

PROGRAM DESCRIPTION This crossfire is designed to educate clinicians regarding the latest clinical trial evidence for PCSK9 inhibitors (PCSK9i), emphasizing results from studies that evaluated coronary risk and cardiovascular outcomes. ...

Read more about this

I'm interested in this

Share with others

Write the first review

Join now
to leave a review or read peer reviews!

Resource tags
Show all tags


Sign Up

Share with others

I'm interested